jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Indian Journal of Pharmaceutical Education and ResearchNOW IN
Article

Silibinin: An Inhibitor of Mir-181a Gene Expression in Sk-Br-3 Breast Cancer Cell Line

Parvaneh Shahinfar1, Nasrin Motamed2★, Elnaz Birjandian2, Omid Shabanpour3★ Corresponding author

  1. 1Department of Cell and Molecular Biology, School of Biological Sciences, Kharazmi University, Tehran, IRAN.
  2. 2School of Biology, College of Science, University of Tehran, Tehran, IRAN.
  3. 3Faculty of Medicine, Shahrood Islamic Azad University of Medicine, Shahrood, IRAN.

CORRESPONDENCE

Nasrin Motamed

School of Biology, College of Science, University of Tehran, Tehran, IRAN.

motamed2@khayam.ut.ac.ir

Received: 06-01-2017; Revised: 15-02-2017; Accepted: 13-07-2017.

Volume 51, Issue 4 · pp. 597–602 · PUBLISHED 2017 · DOI: 10.5530/ijper.51.4.89

View on IJPER original site ↗

ABSTRACT

Background: Mir-181a has been considered as an attractive molecular target for breast cancer therapy. The main objective of this work is to assess the inhibitory effects of silibinin, a herbal substance, on proliferation, apoptosis and Mir-181a gene expression in human breast cancer cell line SK-BR-3. Materials and Methods: Human breast cancer cell line SK-BR-3 was treated with various concentration of silibinin. Cell viability was assessed by MTT assay and apoptosis by flow cytometry. Expression of human mir-181a gene was measured with real-time PCR. Results: Silibinin inhibits growth of SK-BR-3 cells in a dose- and time-dependent manner and effectively induces apoptosis of SK-BR-3 cells. In addition, silibinin caused a decrease in Mir-181a level. Conclusion: These findings suggest that cell viability along with Mir-181a gene expression in breast cancer cells could be reduced by silibinin. These results suggest that silibinin inhibits the proliferation of SK-BR-3 cells, and it induces apoptosis by down-regulating Mir-181a expression in breast cancer cells.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Shahinfar, P., Motamed, N., Birjandian, E., & Shabanpour, O. (2017). Silibinin: An Inhibitor of Mir-181a Gene Expression in Sk-Br-3 Breast Cancer Cell Line. Indian Journal of Pharmaceutical Education and Research, 51(4), 597–602. https://doi.org/10.5530/ijper.51.4.89